Aurinia Pharmaceuticals (AUPH) Other Gross PP&E Adjustments: 2014-2025
Historic Other Gross PP&E Adjustments for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Sep 2025 value amounting to -$73.5 million.
- Aurinia Pharmaceuticals' Other Gross PP&E Adjustments rose 19.35% to -$73.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$320.6 million, marking a year-over-year increase of 17.65%. This contributed to the annual value of -$86.8 million for FY2024, which is 16.09% up from last year.
- Latest data reveals that Aurinia Pharmaceuticals reported Other Gross PP&E Adjustments of -$73.5 million as of Q3 2025, which was up 5.62% from -$77.9 million recorded in Q2 2025.
- Over the past 5 years, Aurinia Pharmaceuticals' Other Gross PP&E Adjustments peaked at $477,000 during Q1 2023, and registered a low of -$112.2 million during Q2 2023.
- Its 3-year average for Other Gross PP&E Adjustments is -$84.5 million, with a median of -$91.2 million in 2024.
- Within the past 5 years, the most significant YoY rise in Aurinia Pharmaceuticals' Other Gross PP&E Adjustments was 381.82% (2023), while the steepest drop was 88,476.23% (2023).
- Aurinia Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$129,000 in 2021, then skyrocketed by 253.49% to $198,000 in 2022, then slumped by 52,347.98% to -$103.5 million in 2023, then climbed by 16.09% to -$86.8 million in 2024, then grew by 19.35% to -$73.5 million in 2025.
- Its last three reported values are -$73.5 million in Q3 2025, -$77.9 million for Q2 2025, and -$82.3 million during Q1 2025.